DUBs-IN-3 (E0393-GRP)

DUB-IN-3 (compound 22c) inhibits the deubiquitinating enzyme USP8 with an IC50 of 0.56 μM. This compound shows potential for investigating cancer, neurodegenerative disorders, inflammation, viral infections, and cardiovascular conditions.